Influence of Race on Microsatellite Instability and CD8+ T Cell Infiltration in Colon Cancer
Overview
Authors
Affiliations
African American patients with colorectal cancer show higher mortality than their Caucasian counterparts. Biology might play a partial role, and prior studies suggest a higher prevalence for microsatellite instability (MSI) among cancers from African Americans, albeit patients with MSI cancers have improved survival over patients with non-MSI cancers, counter to the outcome observed for African American patients. CD8+ T cell infiltration of colon cancer is postively correlated with MSI tumors, and is also related to improved outcome. Here, we utilized a 503-person, population-based colon cancer cohort comprising 45% African Americans to determine, under blinded conditions from all epidemiological data, the prevalence of MSI and associated CD8+ T cell infiltration within the cancers. Among Caucasian cancers, 14% were MSI, whereas African American cancers demonstrated 7% MSI (P = 0.009). Clinically, MSI cancers between races were similar; among microsatellite stable cancers, African American patients were younger, female, and with proximal cancers. CD8+ T cells were higher in MSI cancers (88.0 vs 30.4/hpf, P<0.0001), but was not different between races. Utilizing this population-based cohort, African American cancers show half the MSI prevalence of Caucasians without change in CD8+ T cell infiltration which may contribute towards their higher mortality from colon cancer.
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer.
Fan W, Su F, Zhang Y, Zhang X, Du Y, Gao Y Biomark Res. 2024; 12(1):89.
PMID: 39183366 PMC: 11346251. DOI: 10.1186/s40364-024-00640-7.
THE JEREMIAH METZGER LECTURE: ENVIRONMENTAL INFLUENCES ON COLORECTAL CANCER.
Carethers J Trans Am Clin Climatol Assoc. 2024; 134:181-199.
PMID: 39135583 PMC: 11316861.
Lawler T, Parlato L, Andersen S Cancer Causes Control. 2023; 35(2):223-239.
PMID: 37688643 PMC: 11090693. DOI: 10.1007/s10552-023-01783-y.
Investigating miR-9 as a mediator in laryngeal cancer health disparities.
Gobin C, Inkabi S, Lattimore C, Gu T, Menefee J, Rodriguez M Front Oncol. 2023; 13:1096882.
PMID: 37081981 PMC: 10112398. DOI: 10.3389/fonc.2023.1096882.
Telisnor G, DeRemer D, Frimpong E, Agyare E, Allen J, Ricks-Santi L J Natl Med Assoc. 2023; 115(2):164-174.
PMID: 36801148 PMC: 10639003. DOI: 10.1016/j.jnma.2023.01.008.